Polygenic risk for anxiety influences anxiety comorbidity and suicidal behavior in bipolar disorder.


Journal

Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664

Informations de publication

Date de publication:
24 08 2020
Historique:
received: 23 04 2020
accepted: 22 07 2020
revised: 10 07 2020
entrez: 26 8 2020
pubmed: 26 8 2020
medline: 22 6 2021
Statut: epublish

Résumé

Bipolar disorder is often comorbid with anxiety, which is itself associated with poorer clinical outcomes, including suicide. A better etiologic understanding of this comorbidity could inform diagnosis and treatment. The present study aims to test whether comorbid anxiety in bipolar disorder reflects shared genetic risk factors. We also sought to assess the contribution of genetic risk for anxiety to suicide attempts in bipolar disorder. Polygenic risk scores (PRS) were calculated from published genome-wide association studies of samples of controls and cases with anxiety (n = 83,566) or bipolar disorder (n = 51,710), then scored in independent target samples (total n = 3369) of individuals with bipolar disorder who reported or denied lifetime anxiety disorders or suicidal attempts in research interviews. Participants were recruited from clinical and nonclinical settings and genotyped for common genetic variants. The results show that polygenic risk for anxiety was associated with comorbid anxiety disorders and suicide attempts in bipolar disorder, while polygenic risk for bipolar disorder was not associated with any of these variables. Our findings point out that comorbid anxiety disorders in bipolar disorder reflect a dual burden of bipolar and anxiety-related genes; the latter may also contribute to suicide attempts. Clinical care that recognizes and addresses this dual burden may help improve outcomes in people living with comorbid bipolar and anxiety disorders.

Identifiants

pubmed: 32839438
doi: 10.1038/s41398-020-00981-5
pii: 10.1038/s41398-020-00981-5
pmc: PMC7445247
doi:

Types de publication

Journal Article Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

298

Subventions

Organisme : Intramural NIH HHS
ID : ZIA MH002843
Pays : United States

Investigateurs

Ney Alliey-Rodriguez (N)
Judith A Badner (JA)
Wade Berrettini (W)
William Byerley (W)
William Coryell (W)
David W Craig (DW)
Howard J Edenberg (HJ)
Tatiana Foroud (T)
Elliot S Gershon (ES)
Tiffany A Greenwood (TA)
Yiran Guo (Y)
Brendan J Keating (BJ)
Daniel L Koller (DL)
William B Lawson (WB)
Chunyu Liu (C)
Pamela B Mahon (PB)
Melvin G McInnis (MG)
Sarah S Murray (SS)
John L Nurnberger (JL)
Evaristus A Nwulia (EA)
Corrie B Panganiban (CB)
John Rice (J)
Nicholas J Schork (NJ)
Erin N Smith (EN)
Peng Zhang (P)
Sebastian Zöllner (S)
Fernando S Goes (FS)
John R Kelsoe (JR)
Caroline M Nievergelt (CM)
James B Potash (JB)
Tatyana Shekhtman (T)
Paul D Schilling (PD)
Peter P Zandi (PP)

Références

Olfson, M. et al. Reexamining associations between mania, depression, anxiety and substance use disorders: results from a prospective national cohort. Mol. Psychiatry 22, 235–241 (2017).
doi: 10.1038/mp.2016.64
Pavlova, B., Perlis, R. H., Alda, M. & Uher, R. Lifetime prevalence of anxiety disorders in people with bipolar disorder: a systematic review and meta-analysis. Lancet Psychiatry 2, 710–717 (2015).
doi: 10.1016/S2215-0366(15)00112-1
MacKinnon, D. F., McMahon, F. J., Simpson, S. G., McInnis, M. G. & DePaulo, J. R. Panic disorder with familial bipolar disorder. Biol. Psychiatry 42, 90–95, https://doi.org/10.1016/S0006-3223(96)00299-5 (1997).
doi: 10.1016/S0006-3223(96)00299-5 pubmed: 9209725
Wozniak, J., Biederman, J., Monuteaux, M. C., Richards, J. & Faraone, S. V. Parsing the comorbidity between bipolar disorder and anxiety disorders: a familial risk analysis. J. Child Adolesc. Psychopharmacol. 12, 101–111 (2002).
doi: 10.1089/104454602760219144
Frank, E. et al. Clinical significance of lifetime panic spectrum symptoms in the treatment of patients with bipolar I disorder. Arch. Gen. Psychiatry 59, 905–911 (2002).
doi: 10.1001/archpsyc.59.10.905
Young, L. T., Cooke, R. G., Robb, J. C., Levitt, A. J. & Joffe, R. T. Anxious and non-anxious bipolar disorder. J. Affect. Disord. 29, 49–52 (1993).
doi: 10.1016/0165-0327(93)90118-4
Toniolo, R. A., Caetano, S. C., da Silva, P. V. & Lafer, B. Clinical significance of lifetime panic disorder in the course of bipolar disorder type I. Compr. Psychiatry 50, 9–12 (2009).
doi: 10.1016/j.comppsych.2008.06.001
Feske, U. et al. Anxiety as a correlate of response to the acute treatment of bipolar I disorder. Am. J. Psychiatry 157, 956–962 (2000).
doi: 10.1176/appi.ajp.157.6.956
Henry, C. et al. Anxiety disorders in 318 bipolar patients: prevalence and impact on illness severity and response to mood stabilizer. J. Clin. Psychiatry 64, 331–335 (2003).
doi: 10.4088/JCP.v64n0316
Simon, N. M. et al. Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am. J. Psychiatry 161, 2222–2229 (2004).
doi: 10.1176/appi.ajp.161.12.2222
Sareen, J. et al. Anxiety disorders and risk for suicidal ideation and suicide attempts: a population-based longitudinal study of adults. Arch. Gen. Psychiatry 62, 1249–1257 (2005).
doi: 10.1001/archpsyc.62.11.1249
Simon, N. M. et al. The association of comorbid anxiety disorders with suicide attempts and suicidal ideation in outpatients with bipolar disorder. J. Psychiatr. Res. 41, 255–264 (2007).
doi: 10.1016/j.jpsychires.2006.08.004
Pagura, J., Cox, B. J., Sareen, J. & Enns, M. W. Factors associated with multiple versus single episode suicide attempts in the 1990–1992 and 2001–2003 United States national comorbidity surveys. J. Nerv. Ment. Dis. 196, 806–813 (2008).
doi: 10.1097/NMD.0b013e31818b6a77
Hou, L. et al. Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder. Hum. Mol. Genet. https://doi.org/10.1093/hmg/ddw181 (2016).
Goes, F. S. Genetics of bipolar disorder. Psychiatr. Clin. 39, 139–155 (2016).
Savage, J. E., Sawyers, C., Roberson-Nay, R. & Hettema, J. M. The genetics of anxiety-related negative valence system traits. Am. J. Med Genet. Part B Neuropsychiatr. Genet. Publ. Int Soc. Psychiatr. Genet. 174, 156–177 (2017).
doi: 10.1002/ajmg.b.32459
Otowa, T. et al. Meta-analysis of genome-wide association studies of anxiety disorders. Mol. Psychiatry 21, 1485 (2016).
doi: 10.1038/mp.2016.11
Purves, K. L. et al. A major role for common genetic variation in anxiety disorders. Mol Psychiatry https://doi.org/10.1038/s41380-019-0559-1 (2019).
Purcell, S. M. et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460, 748–752 (2009).
doi: 10.1038/nature08185
Collins, A. L. et al. Identifying bipolar disorder susceptibility loci in a densely affected pedigree. Mol. Psychiatry 18, 1245–1246 (2013).
doi: 10.1038/mp.2012.176
Ruderfer, D. M. et al. Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia. Mol. Psychiatry 19, 1017–1024 (2014).
doi: 10.1038/mp.2013.138
International Consortium on Lithium Genetics (ConLi+Gen), Amare, A. T. et al. Association of polygenic score for schizophrenia and HLA antigen and inflammation genes with response to lithium in bipolar affective disorder: a Genome-Wide Association Study. JAMA Psychiatry 75, 65–74 (2018).
pubmed: 29121268
Hamshere, M. L. et al. Polygenic dissection of the bipolar phenotype. Br. J. Psychiatry J. Ment. Sci. 198, 284–288 (2011).
doi: 10.1192/bjp.bp.110.087866
Colodro-Conde, L. et al. A direct test of the diathesis-stress model for depression. Mol Psychiatry. https://doi.org/10.1038/mp.2017.130 (2017).
Wray, N. R. et al. Research review: polygenic methods and their application to psychiatric traits. J. Child Psychol. Psychiatry 55, 1068–1087 (2014).
doi: 10.1111/jcpp.12295
Visscher, P. M. et al. 10 Years of GWAS discovery: biology, function, and translation. Am. J. Hum. Genet. 101, 5–22 (2017).
doi: 10.1016/j.ajhg.2017.06.005
Smith, E. N. et al. Genome-wide association study of bipolar disorder in European American and African American individuals. Mol. Psychiatry 14, 755–763 (2009).
doi: 10.1038/mp.2009.43
Smith, E. N. et al. Genome-wide association of bipolar disorder suggests an enrichment of replicable associations in regions near genes. PLoS Genet. 7. https://doi.org/10.1371/journal.pgen.1002134 (2011).
Nurnberger, J. L. Jr et al. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiave. Arch. Gen. Psychiatry 51, 849–859 (1994).
doi: 10.1001/archpsyc.1994.03950110009002
Potash, J. B. et al. The bipolar disorder phenome database: a resource for genetic studies. Am. J. Psychiatry 164, 1229–1237 (2007).
doi: 10.1176/appi.ajp.2007.06122045
Bergen, S. E. et al. Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder. Mol. Psychiatry 17, 880–886 (2012).
doi: 10.1038/mp.2012.73
Mullins N., Bigdeli T. B., Børglum A. D. GWAS of Suicide Attempt in Psychiatric Disorders and Association with Major Depression Polygenic Risk Scores. Am J Psychiatry. https://doi.org/10.1176/appi.ajp.2019.18080957 (2019).
Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559–575 (2007).
doi: 10.1086/519795
Stahl, E. A. et al. Genome-wide association study identifies 30 loci associated with bipolar disorder. Nat. Genet. 51, 793–803 (2019).
doi: 10.1038/s41588-019-0397-8
Dudbridge, F. Power and predictive accuracy of polygenic risk scores. PLoS Genet. 9, e1003348 (2013).
pubmed: 23555274 pmcid: 23555274
Palla, L. & Dudbridge, F. A fast method that uses polygenic scores to estimate the variance explained by genome-wide marker panels and the proportion of variants affecting a trait. Am. J. Hum. Genet 97, 250–259 (2015).
doi: 10.1016/j.ajhg.2015.06.005
Merikangas, K. R. & Kalaydjian, A. Magnitude and impact of comorbidity of mental disorders from epidemiologic surveys. Curr. Opin. Psychiatry 20, 353–358 (2007).
doi: 10.1097/YCO.0b013e3281c61dc5
Ohi K. et al. Shared genetic etiology between anxiety disorders and psychiatric and related intermidiate phenotypes. Psychol. Med. https://doi.org/10.1017/S003329171900059X (2019).
Nordsletten, A. E. et al. Patterns of nonrandom mating within and across 11 major psychiatric disorders. JAMA Psychiatry 73, 354–361 (2016).
doi: 10.1001/jamapsychiatry.2015.3192
Reinares, M. et al. Family functioning in bipolar disorder: characteristics, congruity between patients and relatives, and clinical correlates. Psychiatry Res. 245, 66–73 (2016).
doi: 10.1016/j.psychres.2016.08.010
Cosci, F. & Fava, G. A. Staging of mental disorders: systematic review. Psychother. Psychosom. 82, 20–34 (2013).
doi: 10.1159/000342243

Auteurs

Fabiana L Lopes (FL)

Intramural Research Program, National Institute of Mental Health, National Institutes of Health, US Department of Health & Human Services, Bethesda, MD, USA. fabiana.lopes@nih.gov.

Kevin Zhu (K)

Intramural Research Program, National Institute of Mental Health, National Institutes of Health, US Department of Health & Human Services, Bethesda, MD, USA.

Kirstin L Purves (KL)

King's College London, Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, London, UK.

Christopher Song (C)

Intramural Research Program, National Institute of Mental Health, National Institutes of Health, US Department of Health & Human Services, Bethesda, MD, USA.

Kwangmi Ahn (K)

Intramural Research Program, National Institute of Mental Health, National Institutes of Health, US Department of Health & Human Services, Bethesda, MD, USA.

Liping Hou (L)

Intramural Research Program, National Institute of Mental Health, National Institutes of Health, US Department of Health & Human Services, Bethesda, MD, USA.

Nirmala Akula (N)

Intramural Research Program, National Institute of Mental Health, National Institutes of Health, US Department of Health & Human Services, Bethesda, MD, USA.

Layla Kassem (L)

Intramural Research Program, National Institute of Mental Health, National Institutes of Health, US Department of Health & Human Services, Bethesda, MD, USA.

Sarah E Bergen (SE)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Mikael Landen (M)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Andre B Veras (AB)

Institute of Psychiatry, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.

Antonio E Nardi (AE)

Institute of Psychiatry, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.

Francis J McMahon (FJ)

Intramural Research Program, National Institute of Mental Health, National Institutes of Health, US Department of Health & Human Services, Bethesda, MD, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH